4000-520-616
欢迎来到免疫在线!(蚂蚁淘生物旗下平台)  请登录 |  免费注册 |  询价篮
主营:原厂直采,平行进口,授权代理(蚂蚁淘为您服务)
咨询热线电话
4000-520-616
当前位置: 首页 > 产品中心 > peptide > Sino Biological/Goat Anti-Rabbit IgG Secondary Antibody (HRP)/1/SSA004
商品详细Sino Biological/Goat Anti-Rabbit IgG Secondary Antibody (HRP)/1/SSA004
Sino Biological/Goat Anti-Rabbit IgG Secondary Antibody (HRP)/1/SSA004
Sino Biological/Goat Anti-Rabbit IgG Secondary Antibody (HRP)/1/SSA004
商品编号: SSA004
品牌: sinobiological
市场价: ¥0.00
美元价: 0.00
产地: 美国(厂家直采)
公司:
产品分类: 多肽合成
公司分类: peptide
联系Q Q: 3392242852
电话号码: 4000-520-616
电子邮箱: info@ebiomall.com
商品介绍
0">
Overview

Description:

Goat polyclonal Secondary Antibody to Rabbit IgG (HRP).

Host

Goat

Target species:

Rabbit IgG

Specificity:

By ELISA this antibody reactsspecifically with Rabbit IgG.

Has cross-reactivitywith guineapig IgG (>10%), rat IgG(2.7%), human IgG (3.6%)

Applications:

WB, ELISA, IHC-P, IP

Properties

Form:

Liquid

Storage & Stability:

Protected from prolonged exposure to light. Store at +4℃ short term (1-2 weeks) (Preservative is recommended to avoid contamination). Upon delivery aliquot. Store at -20℃ to -80℃ for twelve months from date of receipt. Avoid repeated freeze-thaw cycles.

Constituents:

PBS

Purification notes:

Immunogenaffinity purified

Formulation:

Antiserum was solid phase adsorbed to ensure classspecificity. This antibody was isolated by affinity chromatography usingantigen coupled to agarose beads and conjugated to HorseRadish Peroxidase (HRP).

Applications

The application notes include recommended startingdilutions, optimal dilutions/concentrations should be determined by the enduser.

IHC-P

0.2-5 μg/mL

ELISA

0.005-0.2 μg/mL

WB

0.02-0.5 μg/mL

(Colormetric: 0.02-0.5 μg/mL; Chemiluminescent: 0.001-0.5 μg/mL)

IP

0.02-0.5 μg/mL

0">
0">
  • Expression of Programmed cell death protein 1 (PD-1) and Indoleamine 2,3-dioxygenase (IDO) in the tumor microenvironment and in tumor-draining lymph nodes of breast cancer
    Author
    Ye, Q;Wang, C;Xian, J;Zhang, M;Cao, Y;Cao, Y;
    Year
    2018
    Journal
    Hum. Pathol.
    Application
    WB
    PubMed ID: 29447919FoldedExpand
  • The research progress of p53 tumour suppressor activity controlled by Numb in triple-negative breast cancer
    Author
    Jie, X;Cheng, Y;Xue, Q;Luo, Y;Cao, Y;Cao, Y;
    Year
    2018
    Journal
    bioRxiv
    Application
    WB
    FoldedExpand
  • An EGLN1 mutation may regulate hypoxic response in cyanotic congenital heart disease through the PHD2/HIF-1A pathway
    Author
    Zhou, Y;Ouyang, N;Liu, L;Tian, J;Huang, X;Lu, T;
    Year
    2019
    Journal
    Genes Dis
    Application
    WB
    PubMed ID: 30906831FoldedExpand
  • The Effects of Hsa-miR-5195-3p on the Proliferation, Migration and Invasion of Human Cervical Cancer SiHa Cells
    Author
    TANG, M;WAN, Q;SUN, S;HU, J;SUN, Z;
    Year
    2020
    Journal
    China Biotechnology
    Application
    WB
    FoldedExpand
  • Progress in the research of p53 tumour suppressor activity controlled by Numb in triple-negative breast cancer
    Author
    Xian, J;Cheng, Y;Qin, X;Cao, Y;Luo, Y;Cao, Y;
    Year
    2020
    Journal
    J. Cell. Mol. Med.
    Application
    WB
    PubMed ID: 32501652FoldedExpand
  • Cholecystokinin type 2 receptor in colorectal cancer: diagnostic and therapeutic target
    Author
    Chang, J;Liu, ZS;Song, DF;Li, M;Zhang, S;Zhao, K;Guan, YT;Ren, HL;Li, YS;Zhou, Y;Liu, XL;Lu, SY;Hu, P;
    Year
    2020
    Journal
    J. Cancer Res. Clin. Oncol.
    Application
    ICC
    PubMed ID: 32488497FoldedExpand
  • Human H-ferritin presenting RBM of spike glycoprotein as potential vaccine of SARS-CoV-2
    Author
    Yao, D;Lao, F;Zhang, Z;Liu, Y;Cheng, J;Ding, F;Wang, X;Xi, L;Wang, C;Yan, X;Zhang, R;Ouyang, F;Ding, H;Ke, T;
    Year
    2020
    Journal
    bioRxiv
    FoldedExpand

If you couldn"t find the specific citation, you can:

  • Find All Citations
  • Submit a CitationGet a Publication Reward
  • Leave Us a Message
品牌介绍
北京义翘神州科技股份有限公司(Sino Biological Inc.)是一家从事生物试剂研发、生产、销售并提供技术服务的生物科技公司,主要业务包括重组蛋白、抗体、基因和培养基等产品,以及重组蛋白、抗体的开发和生物分析检测等服务。义翘神州为全球的药品研发企业和生命科学研究机构提供高质量的生物试剂产品和高水平的技术服务。公司目前生产和销售的现货产品种类超过 4.6 万种,其中重组蛋白约 6,000 种,包括超过 3,800 种人源细胞表达重组蛋白产品,能够全面满足客户对于最接近人体天然蛋白结构和性质的重组蛋白需求;公司还能提供约 12,000 种抗体,其中单克隆抗体数量约 4,600 种,能够覆盖生命科学研究的多个领域,为分子生物学、细胞生物学、免疫学、发育生物学、干细胞研究等基础科研方向和创新药物研发提供「一站式」生物试剂产品和技术服务。义翘神州的客户涵盖大学、科研院所、医药研发企业等国内外各类生物研发单位。目前公司已经在美国、欧洲建立了子公司,已成为生物试剂行业国内领先的科技公司之一。